{
    "2019-07-29": [
        [
            {
                "time": "",
                "original_text": "康业元再发声：公司要求从未止于分红！",
                "features": {
                    "keywords": [
                        "康业元",
                        "分红",
                        "要求"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康业元回应白云山澄清公告：“金戈”收入、利润大增后，广药开始毁约",
                "features": {
                    "keywords": [
                        "康业元",
                        "白云山",
                        "金戈",
                        "收入",
                        "利润",
                        "毁约"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "国产伟哥之争继续 康业元再发公开信称将一一回应广药",
                "features": {
                    "keywords": [
                        "国产伟哥",
                        "康业元",
                        "广药",
                        "公开信"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "李楚源遭康业元千字“逼问”：为何不敢出来一一答复",
                "features": {
                    "keywords": [
                        "李楚源",
                        "康业元",
                        "逼问",
                        "答复"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "广药集团“举报门”持续发酵：康业元今日再发举报信 直指广药董事长李楚源“违法违纪” 诉讼纠纷",
                "features": {
                    "keywords": [
                        "广药集团",
                        "举报门",
                        "康业元",
                        "李楚源",
                        "违法违纪",
                        "诉讼纠纷"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "利益分配不均 金戈小股东“挨欺负”状告白云山 诉讼纠纷",
                "features": {
                    "keywords": [
                        "利益分配",
                        "金戈",
                        "小股东",
                        "白云山",
                        "诉讼纠纷"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "金戈归谁？白云山、康业元利益分配纠纷升级 诉讼纠纷",
                "features": {
                    "keywords": [
                        "金戈",
                        "白云山",
                        "康业元",
                        "利益分配",
                        "纠纷升级",
                        "诉讼纠纷"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "首个国产伟哥药金戈连续5年毛利率超80% 康业元白云山利益分配纠纷升级 诉讼纠纷",
                "features": {
                    "keywords": [
                        "国产伟哥",
                        "金戈",
                        "毛利率",
                        "康业元",
                        "白云山",
                        "利益分配",
                        "纠纷升级",
                        "诉讼纠纷"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}